Health ❯ Healthcare

Sleep Disorders

Obstructive Sleep Apnea Insomnia Sleep Apnea Sleep Aids Symptoms Daytime Sleepiness Impacts Neuropsychiatric Conditions Sleep Quality Obstructive Sleep Apnoea

Long-Term Melatonin Use Linked to Higher Heart Failure and Mortality Risks in Large AHA Analysis

The unpublished electronic health-records study signals an association, prompting clinicians to favor short, low-dose courses with better labeling.

Preliminary AHA Analysis Links Year-Long Melatonin Use to Higher Heart-Failure Risk

Long-Term Melatonin Use Linked to Higher Heart Failure and Mortality Risk in Large EHR Study

AHA Analysis Links Long-Term Melatonin Use to Higher Heart Failure and Death Risk

Long-Term Melatonin Use Tied to Higher Heart Failure and Death in Preliminary AHA Analysis

Toddler Gut Microbes Tied to School-Age Brain Networks and Later Internalizing Symptoms

London GP Warns Loud Snoring, Daytime Sleepiness May Signal Heart-Straining Sleep Apnoea

UK Advice Urges GP Check for Regular 2–3am Awakenings

Most Melatonin Sprays Flunk German Lab Tests, Raising Safety and Labeling Concerns

Short Sleep Shows Rapid Bodily Harm in New Trial as Experts Urge 7–9 Hours

Neck Size Gains Attention as Simple Warning Sign for Hidden Health Risks

Experts Warn Older Adults: Irregular Sleep Raises Cardiovascular and Cognitive Risks

Chronic Sleep Loss Linked to Higher Alzheimer’s Risk as Experts Warn Sleep Debt Can’t Be Repaid

CPAP Therapy Reduces Cardiovascular Events in High-Risk OSA Patients but Increases Risk in Low-Risk Group

Connected Wearables Platform Advances Remote Sleep Apnea Monitoring

BBC's Dr Xand Debunks Viral TikTok Lettuce Juice Sleep Remedy

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

Daytime Sleepiness in Older Adults Linked to Increased Dementia Risk